Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
I-PRF and BCP in Maxillary Sinus Floor Augmentation
NCT06071416Phase 1Not yet recruiting
- Sponsor
- Assiut University
- Start
- Feb 2024
- Primary completion
- Mar 2024
- Modality
- Device-based Delivery
01
Overview
Phase 1, randomised, open-label trial of platelet rich fibrin in Maxillary atrophy (2 arms), sponsored by Assiut University. Primary endpoint: Vertical bone gain at 6 months. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
platelet rich fibrin
03
Conditions
Maxillary atrophy
Beyond the preview
Go deeper on NCT06071416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06071416.